Artigo Revisado por pares

Osteoporosis in severe congenital neutropenia treated with granulocyte colony‐stimulating factor

1995; Wiley; Volume: 89; Issue: 4 Linguagem: Inglês

10.1111/j.1365-2141.1995.tb08441.x

ISSN

1365-2141

Autores

Nick Bishop, Denise Williams, Juliet Compston, Dorothy M. Stirling, Andrew Prentice,

Tópico(s)

Hematological disorders and diagnostics

Resumo

Recombinant human granulocyte colony-stimulating factor (G-CSF) has substantially improved life expectancy for children with severe congenital neutropenia (SCN). Severe osteoporosis, reported in this population, may relate to the disease process, or be a therapeutic side-effect. This report details bone loss, quantitated absorptiometrically and histomorphometrically, in a child with SCN and vertebral collapse, and the positive response to anabolic steroid and bisphosphonate therapy.

Referência(s)